Results 171 to 180 of about 25,098 (228)
Burosumab treatment for FGF23-related hypophosphatemia in a two-year-old girl with McCune-Albright syndrome. [PDF]
Clin Pediatr EndocrinolSaito T +7 more
europepmc +1 more source
Hyperparathyroidism after kidney homotransplantation. I. Relation to homograft function [PDF]
, 1972 Geis, WP, Popovtzer, MM, Starzl, TE
core
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The pathophysiology of hypophosphatemia
Best Practice and Research in Clinical Endocrinology and MetabolismAfter identification of fibroblast growth factor (FGF) 23 as the pivotal regulator of chronic serum inorganic phosphate (Pi) levels, the etiology of disorders causing hypophosphatemic rickets/osteomalacia has been clarified, and measurement of intact FGF23 serves as a potent tool for differential diagnosis of chronic hypophosphatemia.
Nobuaki Ito, Naoko Hidaka, Hajime Kato
exaly +3 more sources
Hypophosphatemia-induced Cardiomyopathy
American Journal of the Medical Sciences, 2016Relatively few studies have been conducted to evaluate the effect of hypophosphatemia on cardiac function. The goal of this review was to determine whether there is an association between hypophosphatemia and cardiac function and to increase awareness of hypophosphatemia-induced cardiomyopathy as a new clinical entity and a reversible cause of heart ...
Nobuhiro, Ariyoshi +4 more
exaly +3 more sources
AJN, American Journal of Nursing, 1985
info:eu-repo/semantics ...
Vincent, Jean Louis, Goldstein, Jacques
openaire +4 more sources
info:eu-repo/semantics ...
Vincent, Jean Louis, Goldstein, Jacques
openaire +4 more sources
Pediatric Nephrology, 2012
Over the last decade the discovery of fibroblast growth factor 23 (FGF23) and the progressive and ongoing clarification of its role in phosphate and mineral metabolism have led to expansion of the diagnostic spectrum of primary hypophosphatemic syndromes. This article focuses on the impairment of growth in these syndromes.
Fernando, Santos +5 more
openaire +2 more sources
Over the last decade the discovery of fibroblast growth factor 23 (FGF23) and the progressive and ongoing clarification of its role in phosphate and mineral metabolism have led to expansion of the diagnostic spectrum of primary hypophosphatemic syndromes. This article focuses on the impairment of growth in these syndromes.
Fernando, Santos +5 more
openaire +2 more sources